Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
The case alleges Snowflake misled investors about revenue headwinds from product changes.
-
The case alleges Boston Scientific misled investors about its US EP segment's growth and competitive risks.
-
The Soleno complaint alleges that Soleno Phase 3 clinical trial program for DCCR had downplayed, misrepresented, and/or concealed safety concerns.
-
The monday.com complaint alleges that defendants misled investors by providing materially flawed statements of confidence and growth projections.
-
The case alleges Gartner was not equipped to handle ongoing challenges in its industry to meet consulting revenue targets or to maintain its CV growth rate
-
Robbins Geller is investigating whether Super Micro and certain of its top executives made materially false and/or misleading statements to investors.
-
The case alleges Navan failed to disclose it would increase its sales and marketing expenses by 39% just months after the IPO.
-
The Eos Energy complaint alleges that Eos Energy was unable to achieve the ramp in production and capacity utilization required to achieve guidance.
-
The case alleges that Driven Brands misled investors as to its financial condition and the effectiveness of its internal controls over financial reporting.
-
The case alleges that defendants recklessly understated the regulatory risk facing Trip.com as a result of its monopolistic business activities.